5-hydroxytryptamine receptor 2C — Drug Target

All drugs that target 5-hydroxytryptamine receptor 2C — marketed and clinical-stage. Includes 4 drug classes acting on this target.

Drug classes

Atypical Antipsychotic [EPC] · sertindole · metixene · Serotonin-2c Receptor Agonist

Marketed (4)

• Saphris · Hisamitsu · Atypical Antipsychotic [EPC] · Neuroscience
  Saphris works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2C.
• Zerdol · H. Lundbeck A/S · sertindole · Neuroscience
• Metixen · Novartis · metixene · Neuroscience
• Belviq · Eisai · Serotonin-2c Receptor Agonist · Metabolic